Herbal Medicine and Related Products Labelling Regulations 2019
Herbal Medicine and Related Products Labelling Regulations 2019
Herbal Medicine and Related Products Labelling Regulations 2019
1
ARRANGEMENT OF REGULATIONS
Commencement:
1. Scope
2. Prohibition.
3. Labelling Information
4. Name and Address of Manufacturer, Packer or Distributor
5. No reference to International Bodies etc.
6. Declaration of Ingredients.
7. Brand name/Trade mark
8. Identification Number assigned by the Agency
9. Identification mark
10. Adequate Labelling
11. Labelling of bulk package
12. Labelling Information for Practitioners
13. Information on Package insert
14. Prohibition of Labelling of Herbal Medicine and Related Products for certain treatments
15. Herbal Medicine and Related Products not for use in pregnancy & children below 5 years
16. Warning for Children.
17. Misleading Information and Misinformation
18. Penalty
19. Forfeiture
20. Interpretation.
21. Repeal
22. Citation
2
Commencement:
In exercise of the powers conferred on the Governing Council of the National Agency for
Food and Drug Administration and Control (NAFDAC) by Sections 5 and 30 of the
NAFDAC Act Cap N1 LFN 2004 and Section 12 of the Food, Drugs and Related Products
(Registration, Etc.) Act Cap F33 LFN 2004 and of all the powers enabling it in that behalf,
THE GOVERNING COUNCIL OF THE NATIONAL AGENCY FOR FOOD AND
DRUG ADMINISTRATION AND CONTROL with the approval of the Honourable
Minister of Health hereby makes the following Regulations:-
1. Scope
These Regulations shall apply to all labelling of complementary and alternative medicine
manufactured, imported, exported, distributed, advertised, displayed for sale or used in Nigeria.
2. Prohibition.
No person shall manufacture, import, export, distribute, advertise or sell any complementary
and alternative medicine unless it is labelled in accordance with the provision of these
Regulations.
3. Labelling Information
(1) The product name shall not be suggestive of therapeutic claim.
(2) Each product shall have a distinct design not similar to any other registered product.
(3) The labelling shall be based whenever possible on data derived from human experience.
(4) No implied claims or suggestions of Herbal Medicine and Related Products may be made, if
there is inadequate evidence of safety or a lack of substantial evidence of effectiveness.
(5) Where a claim of effectiveness or therapeutic indication labelling is made for any Herbal
Medicine and Related Products, it shall carry boldly and in close proximity to the claim, a
statement to the fact that such claim has not been evaluated by NAFDAC, unless such claim
has been clinically proven and deemed satisfactory by the Agency.
3
5. No reference to International Bodies
No reference, direct or indirect to international bodies shall be made upon any label of Herbal
Medicine and Related Products, except as prescribed by the Agency.
6. Declaration of Ingredients.
(1) A quantitative list of ingredients of the Herbal Medicine and Related Products by their
botanical names or, by their common names, shall be declared quantitatively on the label.
(2) Name or index number of colour used in the preparation of Herbal Medicine and Related
Products shall be declared on the label.
(2) Where a Herbal Medicine and Related Products has tertiary, secondary and primary
packaging materials, and the content of a unit pack is reasonably considered to be dispensed
or sold to an end-user as a whole or is for a single use, the NAFDAC Reg. No. shall be
shown on the tertiary and secondary packaging materials only.
9. Identification mark
(1) Where tablets, capsules, caplets and similar dosage forms bear identification marks, the
identification marks shall be traceable to the Certificate of Registration Holder or the
manufacturer of the herbal product.
(2) Requests for exemptions shall be made in writing to the Agency giving reasons why a waiver
is justified.
4
10. Adequate Labelling
Herbal Medicine and Related Products shall be properly labelled with the following information
displayed clearly on the principal display panel or information panel as the case may apply on
the inner and outer package labels:
(1) The brand name, botanical or common name, if any, shall be qualified as herbal,
homeopathic, animal or mineral medicinal product and or admixture thereof.
(2) A quantitative list of all ingredients of the product by their botanical or common names.
(3) The net content of the product in terms of weight, measure, or numerical count and shall be
in metric unit.
(4) The name and full factory location address of the manufacturer.
(5) Adequate directions for safe use of the product, including amount for use in specific age
groups.
(6) The lot or batch number.
(7) The manufacture and expiration dates.
(8) The storage conditions
(9) Dosage, route and frequency of administration.
(10) Indication for the product,
And any other requirements specified by the Agency.
5
13. Information on Package insert
Relevant information required to appear on the package insert for Practitioners shall include:
(1) Product name
(2) Description;
(3) Clinical Pharmacology or as applicable;
(4) Indications and usage;
(5) Contraindications;
(6) Warnings;
(7) Precautions;
(8) Dosage and administration;
(9) Side effects and Adverse reactions;
(10) Drug abuse and dependence, or as applicable;
(11) Symptoms of over dosage and treatment;
(12) Presentation;
(13) Storage conditions;
14. Prohibition of Labelling of Herbal Medicine and Related Products for certain
treatments.
(1) No person shall label Herbal Medicine and Related Products as a treatment, preventive
or cure for any of the diseases, disorders or abnormal states as identified in schedule 1 to
CAP F32 LFN 2004.
(2) No person shall sell, advertise, display or orally present any Herbal Medicine and Related
Products to the general public whose label contains such words as "for vitality”.
15. Herbal Medicine and Related Products not for use in pregnancy & children [below 5
years]
Both the inner and outer labels of all Herbal Medicine and Related Products shall carry a
warning statement directing pregnant women and children [below 5 years of age] not to use
them, except there is adequate evidence of safety in pregnancy and children under 5 years of age.
6
17. Misleading Information and Misinformation
(1) No person shall sell, advertise, display or use any Herbal Medicine and Related Products with
a name suggestive of the symptom, disorders, diseases or abnormal states that it is supposed
to treat, prevent or cure.
(2) The label of Herbal Medicine and Related Products with antipyretic and analgesic property
shall not bear the indication "for fever" but shall be labelled "for feverish conditions" or
"feverish feeling".
18. Penalty.
(1) Any person who contravenes any of the provisions of these Regulations shall be guilty of an
offence and liable on conviction. In case of :
(a) an individual, to imprisonment for a term not exceeding one year or to a fine not
exceeding N50,000 or to both such imprisonment and fine; and
(b) a body corporate, to a fine not exceeding N100, 000.
(2) Where an offence under these Regulations is committed by a body corporate, firm or other
association of individuals every:-
(a) director, manager, secretary or other similar officer of the body corporate; or
(b) partner or officer of the firm or
(c) trustee of the body concerned ;or
(d) person concerned in the management of the affairs of the association ;or
(e) person who was purporting to act in a capacity referred to in paragraphs (a) to (d) of this
regulation, is severally guilty of that offence and liable to be proceeded against and
punished for that offence in the same manner as if he had himself committed the offence,
unless he proves that the act or omission constituting the offence took place without his
knowledge, consent or connivance.
7
(2) In this section, "proceeds" means any property derived or obtained, directly or indirectly,
through the commission of the offence.
20. Interpretation.
In these regulations, unless the context otherwise requires –
"Agency" means the National Agency for Food and Drug Administration and Control;
"Botanical name" means the scientific name by which the plant is identified;
"Common name" means, with reference to Herbal Medicine and Related Products, the name in
English language or other such language by which the product is commonly known;
"Expiration date" means any date after which Herbal Medicine and Related Products is not
recommended for use;
8
(c) preparation or admixture used for restoring, correcting or modifying organic functions in
man or in animal.
"Label" includes any legend, word or mark attached to, included in, belonging to or
accompanying any Herbal Medicine and Related Products;
"Package" includes anything in which any Herbal Medicine and Related Products is wholly
or partly contained, placed or packed;
"Sell" includes sell, offer for sale, expose for sale, and have in possession for sale.
21. Repeal of Herbal Medicine and Related Products Labelling Regulations 2019
(1) The Herbal Medicine and Related Products Labelling Regulations 2005 is hereby repealed.
(2) The repeal of these Regulations 21 (1) shall not affect anything done or purported to be done
under the repealed Regulations
9
22. Citation
These Regulations may be cited as the Herbal Medicine and Related Products Labelling
Regulations 2019
……………………….
10